| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $233.3M | — |
| Cost of Revenue | $158.3M | — |
| Gross Profit | $75.0M | — |
| R&D Expense | $31.2M | — |
| SG&A Expense | $38.8M | — |
| Operating Income | -$353.0M | — |
| Pre-tax Income | -$364.1M | — |
| Income Tax | -$7.7M | — |
| Net Income | -$356.3M | — |
| EPS (Basic) | -$2.88 | — |
| EPS (Diluted) | -$2.88 | — |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.1M | -30.3% |
| Accounts Receivable | $38.9M | +31.5% |
| Current Assets | $85.6M | -2.6% |
| Total Assets | $464.8M | -39.4% |
| Current Liabilities | $101.9M | +18.2% |
| Long-term Debt | $197.8M | +13.8% |
| Total Liabilities | $319.6M | +14.9% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | — |
| Capital Expenditures | $600K | — |
| Investing Cash Flow | -$8.7M | — |
| Financing Cash Flow | $6.8M | — |
| Free Cash Flow | -$12.6M | — |
| Stockholders' Equity |
| $145.3M |
| -70.3% |